Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery-Reference-Cited by-同舟云学术

Hypoxia-targeted 131I therapy of hepatocellular cancer after systemic mesenchymal stem cell-mediated sodium iodide symporter gene delivery

Published:2016-07-21 Issue:34 Volume:7 Page:54795-54810
ISSN:1949-2553
Container-title:Oncotarget
language:en
Short-container-title:Oncotarget

Author:

Müller Andrea M.¹,Schmohl Kathrin A.¹,Knoop Kerstin¹,Schug Christina¹,Urnauer Sarah¹,Hagenhoff Anna²,Clevert Dirk-André³,Ingrisch Michael³,Niess Hanno⁴,Carlsen Janette⁵,Zach Christian⁵,Wagner Ernst⁶,Bartenstein Peter⁵,Nelson Peter J.²,Spitzweg Christine¹

Affiliation:

1. Department of Internal Medicine II, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany

2. Clinical Biochemistry Group, Medizinische Klinik und Poliklinik IV, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany

3. Department of Clinical Radiology, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany

4. Department of General, Visceral, Transplantation, Vascular and Thoracic Surgery, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany

5. Department of Nuclear Medicine, University Hospital of Munich, Ludwig Maximilian University of Munich, Munich, Germany

6. Department of Pharmacy, Center of Drug Research, Pharmaceutical Biotechnology, Ludwig Maximilian University of Munich, Munich, Germany

Publisher

Impact Journals, LLC

Subject

Oncology

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Imaging of adeno‐associated viral capsids for purposes of gene editing using CEST NMR/MRI;Magnetic Resonance in Medicine;2024-04-23

2. Interleukin-6-controlled, mesenchymal stem cell-based sodium/iodide symporter gene therapy improves survival of glioblastoma-bearing mice;Molecular Therapy - Oncolytics;2023-09

3. The sodium iodide symporter (NIS) as theranostic gene: potential role in pre-clinical therapy of extra-thyroidal malignancies;Clinical and Translational Imaging;2023-01-16

4. Mesenchymal Stem Cell–mediated Image-guided Sodium Iodide Symporter (NIS) Gene Therapy Improves Survival of Glioblastoma-bearing Mice;Clinical Cancer Research;2022-12-14

5. Dual EGFR- and TfR-targeted gene transfer for sodium iodide symporter gene therapy of glioblastoma;Molecular Therapy - Oncolytics;2022-12